A Branford-based biotech, Enrich Therapeutics, recently secured a 12-month Small Business Innovation Research contract from the National Cancer Institute.
The contract, announced in September, is for just under $400,000, financed with federal dollars.
The company said it plans to use the award to further develop its cell/tissue sample processing and cell isolation technology.